Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

NVO 44.95 -0.01 (-0.02%)
price chart
Novo Nordisk: Increasing Obesity Rate A Positive For Stock, But Share Price ...
That company is Danish pharmaceutical giant Novo Nordisk (NVO) which specializes in making products that treat diabetes. The Zero Hedge article is fairly offensive from a humanitarian point of view as it focuses exclusively on the burdens that obese ...
Related articles »  
Notable Drug Stocks: Novo Nordisk A/S (NYSE:NVO), Pharmacyclics (NASDAQ ...
Novo Nordisk A/S (ADR) (NYSE:NVO) recently released its own EP&L. Novo Nordisk A/S (ADR) (NYSE:NVO) shares after opening at $45.32 moved to $45.50 on last trade day and at the end of the day closed at $45.20.
Drug Manufacturers: Teva Pharmaceutical Industries (NYSE:TEVA), Dynavax ...
Novo Nordisk A/S (ADR) (NYSE:NVO) (Analyst Report) has a strong presence in the diabetes care market with one of the broadest diabetes portfolios in the industry.
Novo Nordisk A/S: Reduction of the share capital
Headquartered in Denmark, Novo Nordisk employs approximately 38,000 employees in 75 countries, and markets its products in more than 180 countries.
Related articles »  
MannKind, Top Gainer In The Biopharmaceutical Industry Yesterday
MannKind has spent more than $2 billion over seven years developing the drug. The insulin analogs market has been dominated for years by two drugs, produced by Eli Lilly and Company (LLY) and Novo Nordisk A/S (ADR) (NVO). Novo Nordisk's drug ...
Related articles »